Cadherins and Epithelial-to-Mesenchymal Transition

被引:273
|
作者
Gheldof, Alexander [1 ,2 ]
Berx, Geert [1 ,2 ]
机构
[1] VIB, Dept Mol Biomed Res, Unit Mol & Cellular Oncol, Ghent, Belgium
[2] Univ Ghent, Dept Biomed Mol Biol, B-9000 Ghent, Belgium
来源
关键词
TRANSCRIPTION FACTOR ZEB1; N-CADHERIN; CELL-ADHESION; BETA-CATENIN; EXPRESSION PATTERN; ESTROGEN-RECEPTOR; TUMOR PROGRESSION; UP-REGULATION; BHLH FACTORS; F-ACTIN;
D O I
10.1016/B978-0-12-394311-8.00014-5
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Epithelial mesenchymal transition (EMT) is a process whereby epithelial cells are transcriptionally reprogrammed, resulting in decreased adhesion and enhanced migration or invasion. EMT occurs during different stages of embryonic development, including gastrulation and neural crest cell delamination, and is induced by a panel of specific transcription factors. These factors comprise, among others, members of the Snail, ZEB, and Twist families, and are all known to modulate cadherin expression and, in particular, E-cadherin. By regulating expression of the cadherin family of proteins, EMT-inducing transcription factors dynamically modulate cell adhesion, allowing many developmental processes to take place. However, during cancer progression EMT can be utilized by cancer cells to contribute to malignancy. This is also reflected at the level of the cadherins, where the cadherin switch between E- and N-cadherins is a classical example seen in cancer-related EMT. In this chapter, we give a detailed overview of the entanglement between EMT-inducing transcription factors and cadherin modulation during embryonic development and cancer progression. We describe how classical cadherins such as E- and N-cadherins are regulated during EMT, as well as cadherin 7, -6B, and -11.
引用
收藏
页码:317 / 336
页数:20
相关论文
共 50 条
  • [31] Evidence for and against epithelial-to-mesenchymal transition in the liver
    Xie, Guanhua
    Diehl, Anna Mae
    AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2013, 305 (12): : G881 - G890
  • [32] Effect of pericytes on epithelial-to-mesenchymal transition in melanoma
    Trevino-Villarreal, Jose Humberto
    Sepulveda, Rosalinda
    Cotanche, Douglas A.
    Rogers, Rick A.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (30)
  • [33] Epithelial-to-mesenchymal transition in cancer: complexity and opportunities
    Zhang, Yun
    Weinberg, Robert A.
    FRONTIERS OF MEDICINE, 2018, 12 (04) : 361 - 373
  • [34] Twist, Epithelial-to-Mesenchymal Transition, and Stem Cells
    Phinney, Donald G.
    STEM CELLS, 2011, 29 (01) : 3 - 4
  • [35] Erratum to: Polyamines modulate epithelial-to-mesenchymal transition
    Alessandra Compagnone
    Andrea Bandino
    Floriana Meli
    Vittoria Bravoco
    Carlo Cravanzola
    Maurizio Parola
    Sebastiano Colombatto
    Amino Acids, 2012, 42 : 2535 - 2535
  • [36] Emerging Roles of Epithelial-to-Mesenchymal Transition in Tumorigenesis
    Wang, Zhiwei
    CURRENT CANCER DRUG TARGETS, 2013, 13 (09) : 905 - 905
  • [37] Epithelial-to-mesenchymal transition in endometrioid adenocarcinoma of the endometrium
    Stewart, Colin J. R.
    HUMAN PATHOLOGY, 2013, 44 (09) : 1956 - 1957
  • [38] Epithelial-to-mesenchymal transition in neutrophilic chronic rhinosinusitis
    Ryu, Gwanghui
    Mo, Ji-Hun
    Shin, Hyun-Woo
    CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY, 2021, 21 (01) : 30 - 37
  • [39] Metabolic reprogramming and epithelial-to-mesenchymal transition in cancer
    Sciacovelli, Marco
    Frezza, Christian
    FEBS JOURNAL, 2017, 284 (19) : 3132 - 3144
  • [40] The morphological and molecular features of the epithelial-to-mesenchymal transition
    Gema Moreno-Bueno
    Héctor Peinado
    Patricia Molina
    David Olmeda
    Eva Cubillo
    Vanesa Santos
    José Palacios
    Francisco Portillo
    Amparo Cano
    Nature Protocols, 2009, 4 : 1591 - 1613